Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN104725266B reveals high-yield imide synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel patent CN108047258B offers high-purity aminopyridine borate via nitro-reduction route ensuring supply chain stability and cost reduction in pharma manufacturing.
Novel heterogeneous copper catalyst enables high yield chiral synthesis for pharmaceutical intermediates supply chain optimization and significant cost reduction capabilities for global buyers.
Patent CN1155603C reveals a novel phenol-based deprotection route for 3-cephem compounds, offering high-purity antibiotic intermediates with significant cost reduction in API manufacturing.
Novel route for Crisaborole intermediates avoiding n-BuLi. Improved safety and yield for API manufacturing.
Patent CN101348483A details a cost-effective FeCl3 oxidative coupling route for phenanthroindolizidine derivatives, offering significant supply chain advantages for pharmaceutical manufacturers.
Discover the novel preparation method for chloro-benzothiepin compounds. Enhanced purity, scalable synthesis, and cost-effective pharmaceutical intermediate manufacturing solutions.
Patent CN112047856B details efficient Rh-catalyzed asymmetric hydrogenation for high-purity chiral alpha-amidoaldehydes, offering significant cost reduction and supply chain stability for pharma manufacturing.
Patent CN114181331B reveals a novel thioether-halogen method for synthesizing sugammadex intermediates, offering high purity and cost-effective manufacturing for global supply chains.
Patent CN103880755A reveals a green catalytic route for 2,4,5-triaryl imidazoles using a biodegradable Brönsted acid, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN1958593B details a cost-effective route for Rosuvastatin calcium intermediates using mild conditions, offering significant supply chain advantages for API manufacturers.
Novel stable intermediate route for Montelukast Sodium. Reduces cost and improves yield. Reliable supplier for pharma intermediates.
Novel synthetic route for Olaparib improves yield and purity significantly. Cost-effective manufacturing solution for pharmaceutical intermediates supply chain reliability and scalability.
Novel patent CN106478525A details an iridium-catalyzed tandem synthesis of quinazolones using oximes, offering high atom economy and simplified purification for pharmaceutical intermediates.
Novel patent method reduces toxicity and cost for pharmaceutical intermediates. Safe scale-up and high-purity production capabilities for global supply chains.
Novel patent CN105820101B details high-purity Oxiracetam intermediate synthesis. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing partners globally.
Patent CN111423405A details a novel Pd-catalyzed cross-dehydrogenative coupling route for benzopyran-3-ol derivatives, offering high yield and mild conditions for pharmaceutical intermediates.
Patent CN107805216A reveals a novel copper-catalyzed route for chiral tetrahydropyrrole intermediates, offering superior enantioselectivity and scalable manufacturing advantages.
Patent CN103619815A details a high-yield four-step synthesis for proline compounds. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN119192176B reveals a mild silver-catalyzed route for polysubstituted pyrrolo isoquinoline intermediates, offering significant cost and supply chain advantages for pharmaceutical manufacturing.